| |
| |
|
| Insider
Information: |
Patou Gary |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
37,714 |
|
|
Indirect Shares
|
5,604 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$19,101 |
|
|
| Total
Shares |
43,318 |
|
|
| Total
Value |
$19,101 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Oscient Pharmaceuticals Corp |
OSCIQ |
Director |
2008-06-12 |
14,141 |
2004-11-02 |
0 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Chief Medical Officer |
2014-08-07 |
0 |
2014-08-07 |
702 |
Premium* |
|
|
Xenon Pharmaceuticals Inc. |
XENE |
|
2023-12-13 |
23,573 |
2023-12-14 |
4,902 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
150 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-11-02 |
4 |
AS |
$3.50 |
$1,750 |
D/D |
(500) |
12,253 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-11-02 |
4 |
OE |
$0.07 |
$45 |
D/D |
641 |
12,753 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-01 |
4 |
AS |
$3.54 |
$338,070 |
D/D |
(95,500) |
39,126 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-01 |
4 |
OE |
$0.07 |
$8,566 |
D/D |
122,373 |
134,626 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-02 |
4 |
AS |
$3.50 |
$35,000 |
D/D |
(10,000) |
41,940 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-02 |
4 |
OE |
$1.18 |
$15,121 |
D/D |
12,814 |
51,940 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-03 |
4 |
AS |
$3.57 |
$285,600 |
D/D |
(80,000) |
64,451 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-03 |
4 |
OE |
$1.18 |
$120,963 |
D/D |
102,511 |
144,451 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Director |
– • – |
2004-12-03 |
4/A |
AS |
$3.57 |
$265,965 |
D/D |
(74,500) |
69,951 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-27 |
4 |
AS |
$3.60 |
$36,000 |
D/D |
(10,000) |
41,940 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-27 |
4 |
OE |
$0.07 |
$897 |
D/D |
12,814 |
51,940 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-28 |
4 |
AS |
$3.53 |
$17,650 |
D/D |
(5,000) |
54,347 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-28 |
4 |
OE |
$0.07 |
$448 |
D/D |
6,407 |
48,347 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-29 |
4 |
AS |
$3.53 |
$141,200 |
D/D |
(40,000) |
54,603 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-29 |
4 |
OE |
$0.07 |
$3,588 |
D/D |
51,256 |
94,603 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-30 |
4 |
AS |
$3.55 |
$77,745 |
D/D |
(21,900) |
100,765 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2004-12-30 |
4 |
OE |
$0.07 |
$55,504 |
D/D |
111,062 |
169,090 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-01-07 |
4 |
AS |
$3.70 |
$37,000 |
D/D |
(10,000) |
171,904 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-01-07 |
4 |
OE |
$0.07 |
$897 |
D/D |
12,814 |
181,904 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-01-25 |
4 |
OE |
$0.07 |
$11,900 |
D/D |
170,000 |
341,904 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-01-26 |
4 |
OE |
$0.07 |
$1,556 |
D/D |
22,222 |
364,126 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-01-26 |
4 |
AS |
$3.25 |
$65,500 |
D/D |
(20,000) |
344,126 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-01-31 |
4 |
AS |
$3.23 |
$64,600 |
D/D |
(20,000) |
346,348 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-01-31 |
4 |
OE |
$0.07 |
$1,556 |
D/D |
22,222 |
366,348 |
|
- |
|
| OSCIQ |
Oscient Pharmaceuticals C... |
Chief Medical Officer |
• – – |
2005-02-17 |
4 |
AS |
$3.00 |
$30,000 |
D/D |
(10,000) |
367,459 |
|
- |
|
150 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
